News Focus
News Focus
icon url

rafunrafun

02/07/17 10:39 AM

#99696 RE: jfmcrr #99688

You bring up a very interesting and perhaps the most important topic to AMRN investors - WHAT TO DO 'WHEN' PPS SKYROCKETS FOLLOWING REDUCE-IT RESULTS.

Obviously at this point, there is no right or wrong answer as it will be strictly personal decisions, but I think it would benefit many people if others voiced their opinions on this. And by skyrocketing, I mean something like from $5 to $20, immediately thereafter.

One Correctional is that if results are great, I got no matter how high PPS jumps in one day, it will only be the beginning, for many reasons mentioned repeatedly on here. However, that's when everyone's personal situation comes in effect. Personally, even if I am 90% confident that PPS will skyrocket after skyrocketing from RI results (from $20 to $50), would I be willing he risked leaving so much money on the table? To me, the answer is no.

My hope is to develop a plan of action NOW, so that I don't act on impulse, when it occurs.

I'm thinking something like (re- PPS immediately following great RI results):

If < $10, don't touch;
If $10 - $15, sell 30%
If $15 - $25 sell 50%
If > $25 sell 60-70%



icon url

ziploc_1

02/07/17 11:21 AM

#99707 RE: jfmcrr #99688

jfm:"There are a lot of moving parts and some work should be done before the events."...Although this is true for the investor, it is even more true for Amarin management.

IMO it is important for Amarin to begin looking beyond a positive R-IT. It would be short sighted for Amarin to wait until there are sufficient funds in the till to do everything that needs to be done....including enhanced U.S. marketing and new studies to develop further indications and markets for Vascepa.. Amarin should already be talking to banks about obtaining additional credit after a positive R-IT.